Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Seqirus,Adjuvanted inactivated trivalent influenza vaccine (aTIV),Influenza vaccine for people 65 years of age and over,Adjuvanted inactivated trivalent influenza vaccine (aTIV) (Fluad),Options for investment,Community and Hospital,National Immunisation Schedule
